In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

American Chamber of Commerce in Korea, PhRMA Join Forces To Help Boost Korean Healthcare Drive

This article was originally published in PharmAsia News

Executive Summary

SEOUL - The South Korean government is revving up its healthcare projects, and the American Chamber of Commerce in Korea and the Pharmaceutical Research Manufacturers of America held their first "2010 Korea-US Healthcare Innovation Seminar" to cooperate with their Korean counterparts

You may also be interested in...



U.S. And Korea Step Up Fight Against Tuberculosis, Launch TB Research Center

SEOUL - In a bid to wipe out perceptions that South Korea remains a "safe heaven" for tuberculosis, the country is strengthening cooperation with the U.S. in a joint attack on the potentially fatal disease

Korea Targets Biologics, Devices, Health Care Among Economic Growth Projects For Next Decade

SEOUL - South Korean President Lee Myung-bak named "17 new growth engines" at a science and technology council meeting at his office in Seoul Jan. 13. Expected to spearhead the country's economic growth for the next 10 years, of those 17 economic growth engines, the Korean government targeted biologics, medical devices and global health care among the national priorities

PharmAsia News Business Bulletin

A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).

Latest Headlines
See All
UsernamePublicRestriction

Register

SC075383

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel